Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.
about
The vitamin D-antimicrobial peptide pathway and its role in protection against infectionThe human intestinal microbiome: a new frontier of human biologyRegulation of immune cell function by short-chain fatty acidsRegulation of the Intestinal Barrier Function by Host Defense PeptidesFecal biomarkers of intestinal health and disease in childrenAntimicrobial proteins in intestine and inflammatory bowel diseasesUnc119 protects from Shigella infection by inhibiting the Abl family kinasesPhenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategyLactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasisThe antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.The role of the antimicrobial peptide cathelicidin in renal diseases.Immunopathogenesis of polymicrobial otitis media.Regulation of bacterial pathogenesis by intestinal short-chain Fatty acids.Sodium butyrate improves porcine host defense peptide expression and relieves the inflammatory response upon Toll-like receptor 2 activation and histone deacetylase inhibition in porcine kidney cells.The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airwayDifferential cathelicidin expression in duodenal and gastric biopsies from Tanzanian and German patients.Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression.Antidiarrheal activity of extracts and compound from Trilepisium madagascariense stem bark.Immune and genetic gardening of the intestinal microbiome.Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection.Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.Prebiotics to fight diseases: reality or fiction?Inducing endogenous antimicrobial peptides to battle infections.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosisBoosting innate immunity: development and validation of a cell-based screening assay to identify LL-37 inducers.Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogs.Interaction of Salmonella spp. with the Intestinal MicrobiotaL-isoleucine-supplemented oral rehydration solution in the treatment of acute diarrhoea in children: a randomized controlled trialContribution of microbiota to the intestinal physicochemical barrier.Human polymorphisms as clinical predictors in leprosyPhenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3.Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitisVirulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expressionRegulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon EpitheliaShigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?Bacteria in the intestine, helpful residents or enemies from within?
P2860
Q24647840-95B7F3F6-C5DA-4B84-A8C0-38AA60BFF025Q24649671-A081E665-973E-4E59-9114-BBCED6B7175BQ26748416-89A1852C-A84C-47C0-B642-8B2CC56054B0Q26776055-173FD510-A9E3-40C7-A46D-872CBF80F007Q27021773-A73BBCDC-1E33-44A9-A2BA-2C98E3C1D356Q27023239-4BC07EB5-D48F-4BA9-8F28-6F83A37F5D5FQ28475302-68A66B07-C898-416A-B5CC-4A610D5B4C04Q28478430-52D8A634-D355-4995-A040-371813E9623BQ28484943-D0675F84-316F-4098-8028-121D53F3F1ECQ33403877-6CB522AD-ED94-469B-B42A-9E0C1B450C13Q33417340-F93C6EEC-464B-4EB3-A058-547C8A1D47E0Q33615253-0E7F7333-D5DF-422E-B579-989B27D5D280Q33642076-142A5EBE-E18B-484B-88B3-0EC0B70C32BBQ33688734-D1BC43E3-A6FA-4E1D-9040-E2B59EF6CCE7Q33719376-AB9F9CA1-FFF5-4024-A1ED-9B30BB6FB8B7Q33979642-46305EF2-D208-4585-AA96-9CE1F6D8C37AQ34071870-EC81EA1B-9DE0-4064-9877-83660E82479DQ34118881-E0E63A73-9A49-4437-A59D-2D7942A46EC1Q34143465-1241F62E-CBEA-49FE-83A4-DFD22C350B28Q34265202-6CBB9EC3-A8B8-4964-A024-1018B8DD7029Q34295528-8E7F35F1-B96B-4D26-9099-CCC789FDD9D1Q34457000-ABCA6CA3-C8FE-49EB-A0DA-E70AC2AD05AAQ34529060-79D5C47A-2F67-4DF9-BD4D-BE687953A890Q34534908-13588077-DE62-4647-9B9C-BFEA30927D5CQ34655555-3BB8324B-152C-4C6B-93D6-F7AF9643B880Q34670730-CC8909E4-9E09-4A80-9AAB-B242457EB064Q34864069-1C88FDC8-53F7-4C26-8BF3-A8A340E8840AQ34983653-63C537C6-BB3B-4A5A-9BA0-45B4628DCFA3Q35090110-6E2AEF8E-552F-4B4E-91B6-80C637AF42AFQ35090271-727BA131-8E18-41D4-849F-20C819D493ABQ35292478-74BCEB0E-971E-420A-8D9A-D884BA9ADBB9Q35636319-D1117F57-4BF4-4032-8854-08CA98AA6B91Q35680478-99CA738F-31DC-45A7-B012-E707DE8F72A4Q35783492-AAC439CD-DE65-4548-996D-4876631FBCD9Q36422076-E9CB0ED0-BFD8-4B54-9CB5-D2E20031FECBQ36640009-B8CA05BE-40B9-493E-B3EC-A57D4830CFC5Q36655079-AF7D678F-A475-494F-B038-B43FFB7B0857Q36683648-B49CFD34-34B2-4D99-9CEA-BA69E508444EQ36703588-40CFEBFC-55DB-43D8-85D0-AE1AF752ADB3Q36804240-38636514-1210-43B6-8D47-618E5425F12D
P2860
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@ast
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@en
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@nl
type
label
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@ast
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@en
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@nl
prefLabel
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@ast
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@en
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@nl
P2093
P2860
P50
P356
P1476
Improved outcome in shigellosi ...... endogenous peptide antibiotic.
@en
P2093
Gudmundur H Gudmundsson
Jan Andersson
K M Nasirul Islam
Monica Lindh
Peter Bergman
Protim Sarker
P2860
P304
P356
10.1073/PNAS.0602888103
P407
P577
2006-06-01T00:00:00Z